Related Experiment Videos
Synthetic substrates for human factor VIIa and factor VIIa-tissue factor
S Butenas1, N Ribarik, K G Mann
1Department of Biochemistry, University of Vermont, Burlington 05405.
Biochemistry
|July 6, 1993
Summary
Researchers developed novel tripeptide fluorogenic substrates to study factor VIIa activity. Optimal substrate design involves specific amino acid substitutions, enhancing factor VIIa-tissue factor complex hydrolysis.
Area of Science:
- Biochemistry
- Enzymology
- Drug Discovery
Background:
- Factor VIIa is a key enzyme in the coagulation cascade.
- Developing specific substrates is crucial for studying enzyme kinetics and inhibitor screening.
Purpose of the Study:
- To synthesize and characterize novel tripeptide fluorogenic substrates.
- To evaluate substrate efficiency for factor VIIa, particularly in the presence of tissue factor (TF).
Main Methods:
- Synthesis of 100 tripeptide fluorogenic substrates with varying P1, P2, P3 amino acids, and P' detecting groups.
- Kinetic analysis (kcat/KM) of substrate hydrolysis by factor VIIa, factor VIIa-TF complex, and factor Xa.
Main Results:
- Most substrates showed higher efficiency (kcat/KM) for the factor VIIa-TF complex than for factor Xa.
- Optimal P2 amino acids (Val, Pro) and P3 amino acids (Phe) significantly enhanced substrate hydrolysis rates.
- Tissue factor (TF) increased substrate amidolytic activity by an average of 58-fold.
Conclusions:
- Substrate structure, particularly P2 and P3 amino acid identity, critically influences factor VIIa hydrolysis.
- TF significantly potentiates the activity of these substrates towards factor VIIa.
- These substrates are valuable tools for investigating factor VIIa function and developing targeted therapeutics.